ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 68 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 30.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $11,000 | +37.5% | 10,189 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -88.1% | 10,189 | -67.6% | 0.00% | – |
| Q3 2018 | $67,000 | -2.9% | 31,447 | +5.9% | 0.00% | – |
| Q2 2018 | $69,000 | -8.0% | 29,695 | +24.6% | 0.00% | – |
| Q1 2018 | $75,000 | -11.8% | 23,841 | +15.4% | 0.00% | – |
| Q4 2017 | $85,000 | +44.1% | 20,667 | +57.8% | 0.00% | – |
| Q3 2017 | $59,000 | +34.1% | 13,100 | 0.0% | 0.00% | – |
| Q2 2017 | $44,000 | -98.6% | 13,100 | -96.3% | 0.00% | – |
| Q1 2017 | $3,250,000 | +23.7% | 352,312 | +3.2% | 0.00% | – |
| Q4 2016 | $2,628,000 | -22.1% | 341,271 | +15.6% | 0.00% | – |
| Q3 2016 | $3,373,000 | +3.4% | 295,100 | +11.4% | 0.00% | – |
| Q2 2016 | $3,261,000 | +36.1% | 264,839 | +11.8% | 0.00% | – |
| Q1 2016 | $2,396,000 | -52.2% | 236,832 | +6.5% | 0.00% | -100.0% |
| Q4 2015 | $5,013,000 | +54.0% | 222,314 | +13.3% | 0.00% | – |
| Q3 2015 | $3,256,000 | -33.8% | 196,158 | -11.1% | 0.00% | -100.0% |
| Q2 2015 | $4,919,000 | +1.6% | 220,683 | +17.5% | 0.00% | – |
| Q1 2015 | $4,843,000 | +16.4% | 187,890 | -1.8% | 0.00% | – |
| Q4 2014 | $4,162,000 | +23.1% | 191,404 | +7.2% | 0.00% | – |
| Q3 2014 | $3,380,000 | -10.8% | 178,565 | +9.8% | 0.00% | – |
| Q2 2014 | $3,790,000 | +55.8% | 162,574 | +124.9% | 0.00% | – |
| Q1 2014 | $2,432,000 | +29.7% | 72,285 | +13.8% | 0.00% | – |
| Q4 2013 | $1,875,000 | +293.1% | 63,519 | +104.2% | 0.00% | – |
| Q3 2013 | $477,000 | – | 31,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |